
View larger version (71K):
[in a new window]
|
Fig. 7. Developmental timing of dKap- 3 expression correlates with nuclear entry of dHSF. (A-L) Cycle-11 to cycle-13 embryos were stained with either DAPI, anti-dHSF monoclonal antibodies (HSF panels) or anti-dKap- 3 monoclonal antibodies (Kap- 3 panels). NS, non-shocked Drosophila embryos; HS, heat-shocked embryos. (A,E,I) Cycle 11 embryos; (C,G,K) cycle 12 embryos; (B,F,J,D,H,L) cycle 13 embryos. Clearly present but excluded from the nucleus is dHSF in both non-shocked cycle 11 embryos (E) and heat-shocked cycle 12 embryos (G). Similarly staged embryos display essentially no dKap- 3 staining (I and K). At cycle 13 in non-shocked embryos the dHSF is constitutively nuclear and dKap- 3 is expressed yet largely excluded from the nucleus (J). In heat-shocked cycle 12 embryos the dHSF remains excluded from the nucleus 9 (G) and no dKap- 3 is observed as in non-shocked embryos (K). At cycle 13 in heat-shocked embryos the characteristic puntate pattern of dHSF nuclear staining is observed (panel H) and dKap- 3 remains excluded from the nucleus (L). (M) Analysis of the Kap- 3 mRNA distribution in the cycle 9-10 embryo demonstrates essentially no RNA except in the posterior region (indicated by the arrowhead, panel 1). Adjacent to this embryo is a cycle 13-14 embryo that shows significant levels of Kap- 3 mRNA (panel 1). Analysis of dHSF protein distribution in the cycle 12 embryo shows that dHSF is clearly present within the nucleus of pole cells at this early stage (arrowhead, panel 2), corresponding to the presence of Kap- 3 mRNA in this region of the pre-cycle 13 embryo (panel 1).
|